
Windlas Biotech Limited has informed the Exchange regarding a press release dated January 10, 2025, titled " Windlas Biotech s new state-of-the-art Injectable facility receives GMP Certification ".
Filed with NSE ·

Windlas Biotech Limited has informed the Exchange regarding a press release dated January 10, 2025, titled " Windlas Biotech s new state-of-the-art Injectable facility receives GMP Certification ".
6ix hasn’t read this filing yet.
Follow Windlas Biotech into a list and get an email when it puts out news.
Follow Windlas Biotech